Cargando…
The Association Between Dietary Flavonoid and Lignan Intakes and Incident Type 2 Diabetes in European Populations: The EPIC-InterAct study
OBJECTIVE: To study the association between dietary flavonoid and lignan intakes, and the risk of development of type 2 diabetes among European populations. RESEARCH DESIGN AND METHODS: The European Prospective Investigation into Cancer and Nutrition-InterAct case-cohort study included 12,403 incide...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3836159/ https://www.ncbi.nlm.nih.gov/pubmed/24130345 http://dx.doi.org/10.2337/dc13-0877 |
_version_ | 1782292279629709312 |
---|---|
author | Zamora-Ros, Raul Forouhi, Nita G. Sharp, Stephen J. González, Carlos A. Buijsse, Brian Guevara, Marcela van der Schouw, Yvonne T. Amiano, Pilar Boeing, Heiner Bredsdorff, Lea Clavel-Chapelon, Françoise Fagherazzi, Guy Feskens, Edith J. Franks, Paul W. Grioni, Sara Katzke, Verena Key, Timothy J. Khaw, Kay-Tee Kühn, Tilman Masala, Giovanna Mattiello, Amalia Molina-Montes, Esther Nilsson, Peter M. Overvad, Kim Perquier, Florence Quirós, J. Ramón Romieu, Isabelle Sacerdote, Carlotta Scalbert, Augustin Schulze, Matthias Slimani, Nadia Spijkerman, Annemieke M.W. Tjonneland, Anne Tormo, Maria Jose Tumino, Rosario van der A, Daphne L. Langenberg, Claudia Riboli, Elio Wareham, Nicholas J. |
author_facet | Zamora-Ros, Raul Forouhi, Nita G. Sharp, Stephen J. González, Carlos A. Buijsse, Brian Guevara, Marcela van der Schouw, Yvonne T. Amiano, Pilar Boeing, Heiner Bredsdorff, Lea Clavel-Chapelon, Françoise Fagherazzi, Guy Feskens, Edith J. Franks, Paul W. Grioni, Sara Katzke, Verena Key, Timothy J. Khaw, Kay-Tee Kühn, Tilman Masala, Giovanna Mattiello, Amalia Molina-Montes, Esther Nilsson, Peter M. Overvad, Kim Perquier, Florence Quirós, J. Ramón Romieu, Isabelle Sacerdote, Carlotta Scalbert, Augustin Schulze, Matthias Slimani, Nadia Spijkerman, Annemieke M.W. Tjonneland, Anne Tormo, Maria Jose Tumino, Rosario van der A, Daphne L. Langenberg, Claudia Riboli, Elio Wareham, Nicholas J. |
author_sort | Zamora-Ros, Raul |
collection | PubMed |
description | OBJECTIVE: To study the association between dietary flavonoid and lignan intakes, and the risk of development of type 2 diabetes among European populations. RESEARCH DESIGN AND METHODS: The European Prospective Investigation into Cancer and Nutrition-InterAct case-cohort study included 12,403 incident type 2 diabetes cases and a stratified subcohort of 16,154 participants from among 340,234 participants with 3.99 million person-years of follow-up in eight European countries. At baseline, country-specific validated dietary questionnaires were used. A flavonoid and lignan food composition database was developed from the Phenol-Explorer, the U.K. Food Standards Agency, and the U.S. Department of Agriculture databases. Hazard ratios (HRs) from country-specific Prentice-weighted Cox regression models were pooled using random-effects meta-analysis. RESULTS: In multivariable models, a trend for an inverse association between total flavonoid intake and type 2 diabetes was observed (HR for the highest vs. the lowest quintile, 0.90 [95% CI 0.77–1.04]; P valuetrend = 0.040), but not with lignans (HR 0.88 [95% CI 0.72–1.07]; P valuetrend = 0.119). Among flavonoid subclasses, flavonols (HR 0.81 [95% CI 0.69–0.95]; P valuetrend = 0.020) and flavanols (HR 0.82 [95% CI 0.68–0.99]; P valuetrend = 0.012), including flavan-3-ol monomers (HR 0.73 [95% CI 0.57–0.93]; P valuetrend = 0.029), were associated with a significantly reduced hazard of diabetes. CONCLUSIONS: Prospective findings in this large European cohort demonstrate inverse associations between flavonoids, particularly flavanols and flavonols, and incident type 2 diabetes. This suggests a potential protective role of eating a diet rich in flavonoids, a dietary pattern based on plant-based foods, in the prevention of type 2 diabetes. |
format | Online Article Text |
id | pubmed-3836159 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | American Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-38361592014-12-01 The Association Between Dietary Flavonoid and Lignan Intakes and Incident Type 2 Diabetes in European Populations: The EPIC-InterAct study Zamora-Ros, Raul Forouhi, Nita G. Sharp, Stephen J. González, Carlos A. Buijsse, Brian Guevara, Marcela van der Schouw, Yvonne T. Amiano, Pilar Boeing, Heiner Bredsdorff, Lea Clavel-Chapelon, Françoise Fagherazzi, Guy Feskens, Edith J. Franks, Paul W. Grioni, Sara Katzke, Verena Key, Timothy J. Khaw, Kay-Tee Kühn, Tilman Masala, Giovanna Mattiello, Amalia Molina-Montes, Esther Nilsson, Peter M. Overvad, Kim Perquier, Florence Quirós, J. Ramón Romieu, Isabelle Sacerdote, Carlotta Scalbert, Augustin Schulze, Matthias Slimani, Nadia Spijkerman, Annemieke M.W. Tjonneland, Anne Tormo, Maria Jose Tumino, Rosario van der A, Daphne L. Langenberg, Claudia Riboli, Elio Wareham, Nicholas J. Diabetes Care Original Research OBJECTIVE: To study the association between dietary flavonoid and lignan intakes, and the risk of development of type 2 diabetes among European populations. RESEARCH DESIGN AND METHODS: The European Prospective Investigation into Cancer and Nutrition-InterAct case-cohort study included 12,403 incident type 2 diabetes cases and a stratified subcohort of 16,154 participants from among 340,234 participants with 3.99 million person-years of follow-up in eight European countries. At baseline, country-specific validated dietary questionnaires were used. A flavonoid and lignan food composition database was developed from the Phenol-Explorer, the U.K. Food Standards Agency, and the U.S. Department of Agriculture databases. Hazard ratios (HRs) from country-specific Prentice-weighted Cox regression models were pooled using random-effects meta-analysis. RESULTS: In multivariable models, a trend for an inverse association between total flavonoid intake and type 2 diabetes was observed (HR for the highest vs. the lowest quintile, 0.90 [95% CI 0.77–1.04]; P valuetrend = 0.040), but not with lignans (HR 0.88 [95% CI 0.72–1.07]; P valuetrend = 0.119). Among flavonoid subclasses, flavonols (HR 0.81 [95% CI 0.69–0.95]; P valuetrend = 0.020) and flavanols (HR 0.82 [95% CI 0.68–0.99]; P valuetrend = 0.012), including flavan-3-ol monomers (HR 0.73 [95% CI 0.57–0.93]; P valuetrend = 0.029), were associated with a significantly reduced hazard of diabetes. CONCLUSIONS: Prospective findings in this large European cohort demonstrate inverse associations between flavonoids, particularly flavanols and flavonols, and incident type 2 diabetes. This suggests a potential protective role of eating a diet rich in flavonoids, a dietary pattern based on plant-based foods, in the prevention of type 2 diabetes. American Diabetes Association 2013-12 2013-11-13 /pmc/articles/PMC3836159/ /pubmed/24130345 http://dx.doi.org/10.2337/dc13-0877 Text en © 2013 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. |
spellingShingle | Original Research Zamora-Ros, Raul Forouhi, Nita G. Sharp, Stephen J. González, Carlos A. Buijsse, Brian Guevara, Marcela van der Schouw, Yvonne T. Amiano, Pilar Boeing, Heiner Bredsdorff, Lea Clavel-Chapelon, Françoise Fagherazzi, Guy Feskens, Edith J. Franks, Paul W. Grioni, Sara Katzke, Verena Key, Timothy J. Khaw, Kay-Tee Kühn, Tilman Masala, Giovanna Mattiello, Amalia Molina-Montes, Esther Nilsson, Peter M. Overvad, Kim Perquier, Florence Quirós, J. Ramón Romieu, Isabelle Sacerdote, Carlotta Scalbert, Augustin Schulze, Matthias Slimani, Nadia Spijkerman, Annemieke M.W. Tjonneland, Anne Tormo, Maria Jose Tumino, Rosario van der A, Daphne L. Langenberg, Claudia Riboli, Elio Wareham, Nicholas J. The Association Between Dietary Flavonoid and Lignan Intakes and Incident Type 2 Diabetes in European Populations: The EPIC-InterAct study |
title | The Association Between Dietary Flavonoid and Lignan Intakes and Incident Type 2 Diabetes in European Populations: The EPIC-InterAct study |
title_full | The Association Between Dietary Flavonoid and Lignan Intakes and Incident Type 2 Diabetes in European Populations: The EPIC-InterAct study |
title_fullStr | The Association Between Dietary Flavonoid and Lignan Intakes and Incident Type 2 Diabetes in European Populations: The EPIC-InterAct study |
title_full_unstemmed | The Association Between Dietary Flavonoid and Lignan Intakes and Incident Type 2 Diabetes in European Populations: The EPIC-InterAct study |
title_short | The Association Between Dietary Flavonoid and Lignan Intakes and Incident Type 2 Diabetes in European Populations: The EPIC-InterAct study |
title_sort | association between dietary flavonoid and lignan intakes and incident type 2 diabetes in european populations: the epic-interact study |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3836159/ https://www.ncbi.nlm.nih.gov/pubmed/24130345 http://dx.doi.org/10.2337/dc13-0877 |
work_keys_str_mv | AT zamorarosraul theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT forouhinitag theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT sharpstephenj theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT gonzalezcarlosa theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT buijssebrian theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT guevaramarcela theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT vanderschouwyvonnet theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT amianopilar theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT boeingheiner theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT bredsdorfflea theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT clavelchapelonfrancoise theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT fagherazziguy theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT feskensedithj theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT frankspaulw theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT grionisara theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT katzkeverena theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT keytimothyj theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT khawkaytee theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT kuhntilman theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT masalagiovanna theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT mattielloamalia theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT molinamontesesther theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT nilssonpeterm theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT overvadkim theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT perquierflorence theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT quirosjramon theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT romieuisabelle theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT sacerdotecarlotta theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT scalbertaugustin theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT schulzematthias theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT slimaninadia theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT spijkermanannemiekemw theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT tjonnelandanne theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT tormomariajose theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT tuminorosario theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT vanderadaphnel theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT langenbergclaudia theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT ribolielio theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT warehamnicholasj theassociationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT zamorarosraul associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT forouhinitag associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT sharpstephenj associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT gonzalezcarlosa associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT buijssebrian associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT guevaramarcela associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT vanderschouwyvonnet associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT amianopilar associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT boeingheiner associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT bredsdorfflea associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT clavelchapelonfrancoise associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT fagherazziguy associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT feskensedithj associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT frankspaulw associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT grionisara associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT katzkeverena associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT keytimothyj associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT khawkaytee associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT kuhntilman associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT masalagiovanna associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT mattielloamalia associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT molinamontesesther associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT nilssonpeterm associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT overvadkim associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT perquierflorence associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT quirosjramon associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT romieuisabelle associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT sacerdotecarlotta associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT scalbertaugustin associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT schulzematthias associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT slimaninadia associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT spijkermanannemiekemw associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT tjonnelandanne associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT tormomariajose associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT tuminorosario associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT vanderadaphnel associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT langenbergclaudia associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT ribolielio associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy AT warehamnicholasj associationbetweendietaryflavonoidandlignanintakesandincidenttype2diabetesineuropeanpopulationstheepicinteractstudy |